| Product NDC: | 25010-215 | 
| Proprietary Name: | EDECRIN | 
| Non Proprietary Name: | ethacrynic acid | 
| Active Ingredient(s): | 25 mg/1 & nbsp; ethacrynic acid | 
| Administration Route(s): | ORAL | 
| Dosage Form(s): | TABLET | 
| Coding System: | National Drug Codes(NDC) | 
| Product NDC: | 25010-215 | 
| Labeler Name: | Aton Pharma, Inc. | 
| Product Type: | HUMAN PRESCRIPTION DRUG | 
| FDA Application Number: | NDA016092 | 
| Marketing Category: | NDA | 
| Start Marketing Date: | 19670110 | 
| Package NDC: | 25010-215-15 | 
| Package Description: | 100 TABLET in 1 BOTTLE (25010-215-15) | 
| NDC Code | 25010-215-15 | 
| Proprietary Name | EDECRIN | 
| Package Description | 100 TABLET in 1 BOTTLE (25010-215-15) | 
| Product NDC | 25010-215 | 
| Product Type Name | HUMAN PRESCRIPTION DRUG | 
| Non Proprietary Name | ethacrynic acid | 
| Dosage Form Name | TABLET | 
| Route Name | ORAL | 
| Start Marketing Date | 19670110 | 
| Marketing Category Name | NDA | 
| Labeler Name | Aton Pharma, Inc. | 
| Substance Name | ETHACRYNIC ACID | 
| Strength Number | 25 | 
| Strength Unit | mg/1 | 
| Pharmaceutical Classes | Increased Diuresis at Loop of Henle [PE],Loop Diuretic [EPC] |